Due to health issues, this site is no longer maintained and will be shut down shortly. |
Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
$33.96 +0.60 (1.78%)
As of 03/27/2023 14:11:10 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.